| 2024 |
AUTM congratulates Senators Coons and Tillis for successfully passing S. 2220, the PREVAIL Act, out of the Senate Judiciary Committee
|
| 2024 |
AUTM Joins Higher Ed Organizations To Offer Unified Support for PREVAIL Act, PERA Act and IDEA Act |
| 2024 |
AUTM Comments on the 2024 Guidance Update on Patent Subject Matter Eligibility |
| 2024 |
AUTM Supports Bipartisan IDEA Act
|
| 2024 |
AUTM Commends Introduction of the RESTORE Act.
|
| 2024 |
AUTM Comments on the Impact of the Proliferation of AI and Determinations of Patentability |
| 2024 |
AUTM Comments on NIH's Proposed Mandated Access Plan
|
| 2024 |
AUTM Comments on USPTO’s Notice of Proposed Rulemaking Regarding Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting |
| 2024 |
AUTM Comments on USPTO’s Notice of Proposed PTAB Rulemaking |
| 2024 |
AUTM’s Comments on the USPTO’s Inventorship Guidance for AI-Assisted Inventions |
| 2024 |
AUTM’s Comments in Response to the USPTO’s Request for Comments Regarding “Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace” |
| 2024 |
AUTM joins Higher Ed Coalition Members to issue comments on the NIST draft march-in Framework.
|
| 2024 |
AUTM’s comments in response to NIST’s Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights (Federal Register/Vol. 88, No. 235/Dec. 8, 2023) (“Draft Guidance”)
Find the PowerPoint from the January 29 AUTM webinar here.
|
| 2024 |
Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement |
| 2023 |
AUTM Requests March-In Rights Comment Period Extension
|
| 2023 |
AUTM Comments for OMB Docket OMB-2023-0017 (Guidance for Grants and Agreements)
|
| 2023 |
AUTM Leadership Signs Letter Opposing the WTO's Proposed Waiver of IP rights for COVID-19 Therapeutics and Diagnostics
|
| 2023 |
AUTM’s Comments in Response to the United States Copyright Office’s Notice of Inquiry and Request for Comments Regarding Artificial Intelligence and Copyright (Docket No. 2023-6; Document No. 2023-18624)
|
| 2023 |
AUTM Share Support for the PREVAIL Act
|
| 2023 |
AUTM Throws Support Behind the Patent Eligibility Restoration Act |
| 2023 |
AUTM’s Written Comments Regarding the Workshop on Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer
|
| 2023 |
AUTM’s Comments in Response to the USPTO’s Advance Notice of Proposed Rulemaking (ANPRM) Regarding Changes Under Consideration to Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings Before the Patent Trial and Appeal Board (Docket ID Number: PTO-P-2020-0022)
|
| 2023 |
AUTM Commends NIST on Redesign of iEdison |
| 2023 |
AUTM Writes President Biden
|
| 2023 |
Former AUTM Chair Addresses House Judiciary Subcommittee on Intellectual Property |
| 2023 |
AUTM Responds to USPTO Request for Comments Regarding Artificial Intelligence and Inventorship
|
| 2023 |
AUTM Urges USITC to Reject Any Further Waivers of TRIPS
|
| 2023 |
AUTM Surveys Tech Transfer Offices Regarding Their Use of Domestic Manufacturing Waivers, Finds Few are Issued
|
| 2023 |
AUTM urges House and Senate Commerce-Justice-Science Appropriations Subcommittee to fully fund the tech transfer programs in FY '24
|
| 2023 |
Sign the Letter to Congress Regarding Requirement to Capitalize R&E Expenses |
| 2023 |
AUTM CEO Comments on New Tax Law That Could Block Innovation
|
| 2023 |
AUTM’s Comments on the USPTO Initiatives to Ensure the Robustness and Reliability of Patent Rights (Docket ID Number: PTO-2022-0025)
|
| 2023 |
AUTM Signs Follow-up Brief in Support of Rehearing to Correct Standard Applied to Biotech and Pharmaceutical Patents
|
| 2022 |
AUTM Speaks Out Against Pride in Patent Ownership Act
|
| 2022 |
AUTM Suggests PTAB Changes to USPTO Director Vidal |
| 2022 |
AUTM Lauds Passage of CHIPS Act, Urges Congress to Provide Funding |
| 2022 |
AUTM and allies caution U.S. HHS Secretary Becerra on the devastating impact of misusing the march-in provisions of the Bayh-Dole Act |
| 2022 |
AUTM Urges House Science Leadership to Include Provisions on Technology Transfer in Final USICA Bill |
| 2022 |
Our Chair's Response to the New York Times' Patent Reform Editorial |
| 2022 |
Read the Bayh-Dole Coalition letter to HHS on Xtandi march-in petition |
| 2022 |
AUTM's Comments to Artificial Intelligence R&D Strategic Plan |
| 2022 |
AUTM Releases DOE DEC Survey Findings |
| 2021 |
AUTM Issues Comments to the 2021 SEP Policy Statement |
| 2021 |
AUTM Statement on Bob Dole's Legacy |
| 2021 |
AUTM Signs Brief in Support of Rehearing to Correct Standard Applied to Biotech and Pharmaceutical Patents |
| 2021 |
AUTM Raises DOE DEC Concerns |
| 2021 |
AUTM Signs Brief in Support of Apple |
| 2021 |
AUTM's Comments on USPTO's Patent Eligibility Jurisprudence Study |
| 2021 |
AUTM Expresses Support for USICA Tech Transfer Provision |
| 2021 |
Patent Waiver Strikes Damaging Blow to the Future of Innovation |
| 2021 |
AUTM Joins World IP Coalition Statement Celebrating Innovation, Entrepreneurship, and Creativity |
| 2021 |
AUTM Past Leadership Letter to NIST Supporting Proposal to Clarify the Original Intent of Bayh-Dole |
| 2021 |
AUTM's Comments on NIST's Notice of Proposed Rulemaking Regarding Rights to Federally Funded Inventions and Licensing of Government Owned Inventions |
| 2021 |
AUTM's Statement on Racism Aimed at Asian Americans |
| 2021 |
AUTM's Comments on the National Strategy for Expanding American Innovation |
| 2020 |
AUTM’s Comments on Discretion to Institute Trials Before the Patent Trial and Appeal Board |
| 2020 |
AUTM Joins 300+ American Innovators and Orgs Urging Congress to Support USPTO Patent System Reforms
|
| 2020 |
AUTM's Comments on the Proposed Use of “March-In” Rights for Remdesivir |
| 2020 |
AUTM Calls for Embracing Equity, Diversity and Inclusion |
| 2020 |
AUTM 2019 Canadian Region Director’s Forum Report |
| 2020 |
iEdison Request for Information Regarding the Interagency Edison System for Reporting Federally
Funded Inventions (Docket No. 191126-0092) |
| 2020 |
AUTM’s Comments on Intellectual Property Protections for Artificial Intelligence Innovation
(Docket No. PTO-C-2019-0038) |
| 2019 |
AUTM Comments on Patenting Artificial Intelligence Inventions
(Docket No. PTO-C-2019-0029) |
| 2019 |
IP Attaché Program
AUTM joins in support for robust, coordinated US government efforts to promote American innovation and intellectual property, including the efforts of the U.S. Patent & Trademark Office’s Intellectual Property (IP) Attaché program. |
|
2019
|
STRONGER Patents Act
AUTM joined other associations in a statement of support for the bipartisan Support Technology & Research for Our Nation’s Growth and Economic Resilience (STRONGER) Patents Act to protect the property rights of the inventors that grow the country’s economy.
|
| 2019 |
SUCCESS Act of 2018 (P.L. 115‐273) Joint Statement of the Association of American Medical Colleges, Association of American Universities, Association of Public and Land‐grant Universities, AUTM and Council on Governmental Relations. |
| 2019 |
2019 AUTM and BIO Report
University research has added up to $1.7 trillion to US economy since 1996. Read the full report. |
| 2019 |
AUTM Signals Support for the Regional Innovation Program
View RIS Coalition Letter to House
View RIS Coalition Letter to Senate |
| 2019 |
AUTM Responds to Subject Matter Guidance
AUTM commented on the §101 subject matter eligibility guidance and the §112 guidance on examining computer–implemented functional claim limitations posted in the Federal Register January 7, 2019. |
| 2019 |
International Knowledge/Technology Transfer Leadership Summit Summary
AUTM convened an international summit on technology and knowledge transfer in Sitges, Spain, in September 2018 to connect communities working to strategically analyze the evolution of the field, and its future. To that end, 38 global thought leaders from 18 countries joined the two-day roundtable to discuss some of the critical issues facing the community. You can learn more about their discussion and findings here. |
| 2019 |
AUTM Comments on the NIST Return on Investment Initiative Green Paper
AUTM issued additional feedback on the green paper. A final version is expected in early 2019. |
|
2018
|
World Intellectual Property Organization (WIPO)
AUTM joined a coalition of organizations in a letter to Secretary of State Mike Pompeo. The group urged continued U.S. leadership and engagement in WIPO — such engagement is a critical component of U.S. efforts to promote and protect American innovation around the world.
|
|
2018
|
SUCCESS Act
AUTM joined other higher ed organizations in a statement of support for the Study of Underrepresented Classes Chasing Engineering and Science Success (SUCCESS) Act and efforts to foster greater diversity and inclusion within the innovation ecosystem.
|
|
2018
|
NIST ROI Statement
AUTM issued a response to the National Institute of Standards & Technology (NIST), which is assessing the Federal technology transfer system and soliciting feedback.
|
|
2018
|
PTAB Claim Constuction
AUTM issued comments on the USPTO’s proposed changes to the Claim Construction Standard used in PTAB Proceedings.
|
|
2018
|
Bayh-Dole Rule Changes: What They are, What They Mean
AUTM hosted a free webinar to discuss the changes. View the webinar
|
|
2017
|
AUTM-BIO Report
The licensing of university research has made a significant contribution to US gross domestic product (GDP), industry gross output, and jobs over the last two decades, according to an independent study commissioned by AUTM and the Biotechnology Innovation Organization (BIO). Read it here
|
|
2017
|
STRONGER Patents Act
AUTM joined the Association of American Universities (AAU), Association of Public and Land-grant Universities (APLU) and Council on Governmental Relations (COGR) to release a joint statement regarding the introduction of the Support Technology and Research for Our Nation’s Growth and Economic Resilience (STRONGER) Patents Act in the U.S. Senate.
|
|
2017
|
Letter to the FDA
AUTM joined the Association of American Medical Colleges (AAMC), Association of American Universities (AAU), Association of Public Land-grant Universities (APLU) and the Council On Governmental Relations (COGR) in a letter to Dr. Scott Gottlieb, Comissioner of Food and Drugs at the U.S. Food and Drug Administration. Read the letter
|
|
2017
|
World Intellectural Property Organizaton (WIPO)
AUTM joined other organizations in letter to Secretary Tillerson to emphasize the importance of continued U .S. engagement in the WIPO as a critical component of U.S. efforts to provide effective protection and enforcement of U. S. intellectual property rights, a core component of the Administration’s trade policy agenda.
|
|
2016
|
Federally Funded Inventions
AUTM joined other organiztions to comment on the Rights to Federally Funded Inventions and Licensing of Government Owned Inventions.
|
|
2015
|
Patient Advocacy Groups Concerned About H.R. 9
More than 100 patient advocacy groups sent a joint letter to House and Senate leaders to express concerns that H.R. 9, the "Innovation Act" falls short of preserving important patent protections for biopharmaceutical innovation. Read more.
|
|
2015
|
Senate Testimony on Patent Reform
David Winwood, AUTM’s then President-Elect, testified before the U.S. Senate Committee on Small Business and Entrepreneurship about the importance of maintaining a fair and equitable U.S. patent system from the perspective of U.S. research universities. His testimony took place during a hearing titled, “Patent Reform: Protecting Innovation and Entrepreneurship.” Read testimonial.
|
|
2014
|
AUTM Participates in Capitol Hill Briefing on Tech Transfer Policy
The Congressional Technology Transfer Caucus conducted a Capitol Hill briefing on technology transfer policy reform on January 28. A panel of national experts discussed university R&D commercialization issues as well as proposed policy solutions to accelerate research into the marketplace. Click here to view a video from the briefing.
|